124 related articles for article (PubMed ID: 8785473)
21. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
Zhang YR; Zhang YX; Cao W; Lan XL
J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
[TBL] [Abstract][Full Text] [Related]
22. Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery. Dissecting the mechanism of action.
Bennett MR; Lindner V; DeBlois D; Reidy MA; Schwartz SM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2326-32. PubMed ID: 9409198
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
[TBL] [Abstract][Full Text] [Related]
24. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
[TBL] [Abstract][Full Text] [Related]
25. Quantitative nuclear and cytoplasmic localization of antisense oligonucleotides by capillary electrophoresis with laser-induced fluorescence detection.
McKeon J; Khaledi MG
Electrophoresis; 2001 Oct; 22(17):3765-70. PubMed ID: 11699916
[TBL] [Abstract][Full Text] [Related]
26. Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor.
Tanaka H; Sukhova G; Schwartz D; Libby P
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):12-8. PubMed ID: 8548411
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery.
Morishita R; Gibbons GH; Kaneda Y; Ogihara T; Dzau VJ
Gene; 1994 Nov; 149(1):13-9. PubMed ID: 7958977
[TBL] [Abstract][Full Text] [Related]
28. Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries.
Uchida K; Sasahara M; Morigami N; Hazama F; Kinoshita M
Atherosclerosis; 1996 Jul; 124(1):9-23. PubMed ID: 8800490
[TBL] [Abstract][Full Text] [Related]
29. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty.
Gunn J; Holt CM; Francis SE; Shepherd L; Grohmann M; Newman CM; Crossman DC; Cumberland DC
Circ Res; 1997 Apr; 80(4):520-31. PubMed ID: 9118483
[TBL] [Abstract][Full Text] [Related]
30. Effect of TGF-beta(1) antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglycans in balloon catheter-injured neointima of rabbit carotid arteries.
Merrilees M; Beaumont B; Scott L; Hermanutz V; Fennessy P
J Vasc Res; 2000; 37(1):50-60. PubMed ID: 10720886
[TBL] [Abstract][Full Text] [Related]
31. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig.
Post MJ; Borst C; Kuntz RE
Circulation; 1994 Jun; 89(6):2816-21. PubMed ID: 8205696
[TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides.
Piascik MT; Hrometz SL; Edelmann SE; Guarino RD; Hadley RW; Brown RD
J Pharmacol Exp Ther; 1997 Nov; 283(2):854-68. PubMed ID: 9353407
[TBL] [Abstract][Full Text] [Related]
33. Perspectives on antisense therapy for the prevention of restenosis.
Kipshidze N; Moses J; Shankar LR; Leon M
Curr Opin Mol Ther; 2001 Jun; 3(3):265-77. PubMed ID: 11497351
[TBL] [Abstract][Full Text] [Related]
34. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector.
Steg PG; Feldman LJ; Scoazec JY; Tahlil O; Barry JJ; Boulechfar S; Ragot T; Isner JM; Perricaudet M
Circulation; 1994 Oct; 90(4):1648-56. PubMed ID: 7923648
[TBL] [Abstract][Full Text] [Related]
35. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery.
Miao RQ; Murakami H; Song Q; Chao L; Chao J
Circ Res; 2000 Mar; 86(4):418-24. PubMed ID: 10700446
[TBL] [Abstract][Full Text] [Related]
36. Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells.
Li B; Hughes JA; Phillips MI
Neurochem Int; 1997 Sep; 31(3):393-403. PubMed ID: 9246681
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice.
Saijo Y; Perlaky L; Wang H; Busch H
Oncol Res; 1994; 6(6):243-9. PubMed ID: 7865900
[TBL] [Abstract][Full Text] [Related]
38. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells.
Iversen PL; Zhu S; Meyer A; Zon G
Antisense Res Dev; 1992; 2(3):211-22. PubMed ID: 1490072
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of antisense oligonucleotides.
Agrawal S; Temsamani J; Galbraith W; Tang J
Clin Pharmacokinet; 1995 Jan; 28(1):7-16. PubMed ID: 7712663
[TBL] [Abstract][Full Text] [Related]
40. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.
Ma X; Labinaz M; Goldstein J; Miller H; Keon WJ; Letarte M; O'Brien E
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2546-52. PubMed ID: 11116051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
